Medicare Enrolled

Dr. Vahan Madatovian, MD

Family Medicine · Glendale, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
501 W GLENOAKS BLVD, Glendale, CA 91202
8185499630
In practice since 2007 (18 years)
NPI: 1265650493 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Madatovian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Madatovian? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Madatovian

Dr. Vahan Madatovian is a family medicine specialist in Glendale, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Madatovian performed 1,761 Medicare services across 683 unique beneficiaries.

Between the years covered by Open Payments, Dr. Madatovian received a total of $5,108 from 30 pharmaceutical and/or device companies across 211 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Madatovian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 12% volume in CA $5,108 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,761
Medicare services
Top 12% in CA for family medicine
683
Unique beneficiaries
$51
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~98 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
1,071 $69 $150
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
369 $8 $15
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
172 $45 $120
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
34 $40 $45
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
34 $33 $80
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
31 $100 $200
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
29 $12 $100
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
21 $11 $100
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,108
Total received (2018-2024)
Avg $730/year across 7 years
Top 8% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
211
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,108 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$525
2023
$473
2022
$335
2021
$871
2020
$665
2019
$1,232
2018
$1,009

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$151
Ardelyx, Inc.
$143
ABBVIE INC.
$60
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$50
PFIZER INC.
$47
SHIELD THERAPEUTICS INC
$28
IRONWOOD PHARMACEUTICALS, INC
$23
Novo Nordisk Inc
$22
Top 3 companies account for 67.6% of 2024 payments
All-time payments by company (2018-2024) ›
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,056
Amgen Inc.
$925
Amarin Pharma Inc.
$462
AbbVie Inc.
$329
GlaxoSmithKline, LLC.
$316
PFIZER INC.
$270
Synergy Pharmaceuticals Inc
$219
Ironwood Pharmaceuticals, Inc
$206
Novo Nordisk Inc
$180
Ardelyx, Inc.
$143
Allergan, Inc.
$128
ABBVIE INC.
$114
AbbVie, Inc.
$103
Bausch Health US, LLC
$101
Takeda Pharmaceuticals U.S.A., Inc.
$76
AstraZeneca Pharmaceuticals LP
$58
Boehringer Ingelheim Pharmaceuticals, Inc.
$53
Esperion Therapeutics, Inc.
$46
Hikma Pharmaceuticals USA
$46
Abbott Laboratories
$40
Gilead Sciences, Inc.
$33
TerSera Therapeutics LLC
$30
SHIELD THERAPEUTICS INC
$28
Teva Pharmaceuticals USA, Inc.
$24
Nestle HealthCare Nutrition Inc.
$24
IRONWOOD PHARMACEUTICALS, INC
$23
Kowa Pharmaceuticals America, Inc.
$23
Eyevance Pharmaceuticals LLC
$21
Biogen, Inc.
$18
IDORSIA PHARMACEUTICALS US INC
$17
Top 3 companies account for 47.8% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AJOVY · APRISO · Aimovig · Amitiza · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · CREON · Confirm Rx · EUCRISA · EVENITY · FARXIGA · IBSRELA · JARDIANCE · LINZESS · LYRICA · Linzess · Livalo · MIGRANAL · Mitigare · Motegrity · NEXLETOL · NURTEC ODT · Otezla · Ozempic · Prolia · QMIIZ ODT · QUVIVIQ · Repatha · Rybelsus · SPIRIVA RESPIMAT · SYMBICORT · TOVIAZ · TRELEGY ELLIPTA · TRULANCE · Tobradex ST · Tresiba · Trulance · UBRELVY · VRAYLAR · Vascepa · XIFAXAN · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for family medicine in CA.

Looking for a family medicine specialist in Glendale?
Compare family medicine physicians in the Glendale area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
2,881
Per 100K population
29.3
County median income
$87,760
Nearest hospital
USC VERDUGO HILLS HOSPITAL
1.4 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Madatovian is a clinical cardiology specialist, with above-average Medicare volume (top 12% in CA), with low-engagement industry engagement in the top 8% of CA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Madatovian experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Madatovian performed 1,071 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Madatovian receive payments from pharmaceutical companies?
Yes. Dr. Madatovian received a total of $5,108 from 30 companies across 211 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Madatovian's costs compare to other family medicine physicians in Glendale?
Dr. Madatovian's average Medicare payment per service is $51. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Madatovian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →